Research analyst, medium-term horizon, biotech, small-cap

Expecting Big Revenue Ramp At ULURU In The Coming Quarters

…Scale-Up Issues Impact Revenues In Q1…

On May 16, 2014, ULURU, Inc. (OTCQB:ULUR) reported financial results for the first quarter ending March 31, 2014. Revenues during the quarter totaled only $102k, comprised of $87k in products sales and $15k in licensing and royalty income. Revenues came in below expectations; we had expected revenues to be around $200k. The company noted production issues, as discussed in our last report, continue to delay shipments to distributors.

We remind investors that in the fourth quarter 2013, ULURU had to write off $60,000 in obsolete finished goods and raw materials. Management has been working through increased lead-times and logistical issues associated with ramping of production on Altrazeal. Last year the company changed

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details